Literature DB >> 26557177

A rare cause of acute flaccid paralysis: Human coronaviruses.

Cokyaman Turgay1, Tekin Emine1, Koken Ozlem2, S Paksu Muhammet2, A Tasdemir Haydar1.   

Abstract

Acute flaccid paralysis (AFP) is a life-threatening clinical entity characterized by weakness in the whole body muscles often accompanied by respiratory and bulbar paralysis. The most common cause is Gullian-Barre syndrome, but infections, spinal cord diseases, neuromuscular diseases such as myasthenia gravis, drugs and toxins, periodic hypokalemic paralysis, electrolyte disturbances, and botulism should be considered as in the differential diagnosis. Human coronaviruses (HCoVs) cause common cold, upper and lower respiratory tract disease, but in the literature presentation with the lower respiratory tract infection and AFP has not been reported previously. In this study, pediatric case admitted with lower respiratory tract infection and AFP, who detected for HCoV 229E and OC43 co-infection by the real-time polymerase chain reaction, has been reported for the first time.

Entities:  

Keywords:  Acute flaccid paralysis; child; coronavirus 229E; coronavirus OC43

Year:  2015        PMID: 26557177      PMCID: PMC4611905          DOI: 10.4103/1817-1745.165716

Source DB:  PubMed          Journal:  J Pediatr Neurosci        ISSN: 1817-1745


Introduction

Acute flaccid paralysis (AFP) is a clinical entity characterized by areflexia and/or hyporeflexia and weakness which reaches a maximum within days or weeks.[1] Polioviruses, enterovirus 71, flavivirus, herpes virus, and rabies virus are well-known as viral etiologic agents.[2] In this article, who presented with lower respiratory tract infection and AFP, and was detected to have co-infection of human coronavirus (HCoV) 229E and OC43 is reported. AFP associated with HCoV infections has not been reported previously in the literature, and has been reported for the first time in this article.

Case Report

A 3-year-old girl hospitalized due to the development of shortness of breath and inability to walk 1-day after the beginning of fever, rhinorrhea, cough, and weakness. On the same day, respiratory distress increased, she was intubated, and mechanical ventilation started. On physical examination, she was conscious but swallowing, chewing and speech functions damaged, muscle strength was 0/5 and deep tendon reflexes (DTRs) were absent, the plantar response was flexor. Physical examination of other systems was normal. Complete blood count, electrolytes and blood biochemistry and urinalysis were normal, C-reactive protein was negative and erythrocyte sedimentation rate was 20 mm/h. Chest radiography was normal. Cerebrospinal fluid (CSF) pressure, glucose, and protein were normal. Blood, urine, and CSF cultures were negative. Stool and nasal swab cultures were taken. Electroneuromyography (ENMG) revealed no pathological findings. No abnormalities in the brain and spinal cord magnetic resonance imaging were detected - so intracranial and spinal pathologies were excluded. Intravenous antibiotherapy was given for 10 days. After 48 h of hospitalization, a total of 2 g/kg intravenous immunoglobulin (IVIG) in 3 days was given. Mechanical ventilation lasted 7 days. At the end of this period, muscle strength improved to 2–3/5, DTR became norm active, bulbar paralysis and respiratory distress had regressed. At the end of the 2nd week, she could mobilize and walk with a guide. Lumbar puncture and ENMG repeated in the 3rd week did not reveal any pathological findings and Gullian–Barre syndrome (GBS) was completely excluded. Real-time polymerase chain reaction (PCR) analysis of nasal swab samples was reported to be positive for HCoV 229E and OC43 and HCoV co-infection was diagnosed.

Discussion

Flaccid paralysis occurs by the damage of lower motor neurons in the anterior horn of the spinal cord or peripheral nerves either by direct invasion or parainfectious and/or postinfectious immune-mediated mechanisms.[2] Besides GBS, differential diagnosis of AFP includes: Compressive and inflammatory diseases of spinal cord, the anterior horn motor neurons involvement by infectious (poliomyelitis vaccine-associated poliomyelitis, other enteroviral myelitis, a Japanese encephalitis, and West Nile virus as agents) and vascular pathology, myasthenia gravis, drug and toxins affecting neuromuscular junction (aminoglycosides, organophosphates, snake venom and botulism, etc.), muscle disease such as viral myositis or inflammatory myopathy, hypokalemic periodic paralysis and electrolyte disorders (hypermagnesemia and hypokalemia).[3] Preliminary diagnosis was GBS for this case; however, CSF and ENMG findings in the 1st week of paralysis did not support this diagnosis. During the period of mechanical ventilation muscle strength increased and in this short time DTR normalized, as well as after 3 weeks paralysis started no pathologic findings observed by repeating lumbar puncture and ENMG so GBS was excluded. History, clinical presentation, physical examination, and laboratory tests were totally normal that ruled out toxicological etiology, polio, and botulismus. Members of coronaviridae can cause respiratory, intestinal, hepatic and neurological diseases of various severities in humans and animals.[4] In particular, HCoV OC43 is a neurotrophic, neuroinvasive and neuroinflammatory virus. Experimental animal studies reported that HCoV OC43 causes flaccid paralysis and demyelination.[5] HCoVs can cause neurological symptoms such as seizures and meningoencephalitis in children[6] but AFP has not been reported until now. HCoVs may cause more serious respiratory disease in case of immune suppression and with various respiratory agents rather than single infection.[7] In addition HCoV, 229 and OC43 co-infection causing more severe respiratory disease has been demonstrated by a study.[8] We have reported case of co-infection with HCoV 229E and OC43 detected by real-time PCR analysis of nasal swab samples, and additional different respiratory pathogen has not been demonstrated, it suggests that co-infection caused lower respiratory tract infection and AFP. We believe that HCoV 229E and OC43 co-infection may cause respiratory failure and AFP. Whether IVIG have a role in the treatment needs to be supported by more data from the literature.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  8 in total

Review 1.  Differential diagnosis of acute flaccid paralysis and its role in poliomyelitis surveillance.

Authors:  A Marx; J D Glass; R W Sutter
Journal:  Epidemiol Rev       Date:  2000       Impact factor: 6.222

2.  Glutamate excitotoxicity is involved in the induction of paralysis in mice after infection by a human coronavirus with a single point mutation in its spike protein.

Authors:  Elodie Brison; Hélène Jacomy; Marc Desforges; Pierre J Talbot
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

Review 3.  Infectious causes of acute flaccid paralysis.

Authors:  Tom Solomon; Hugh Willison
Journal:  Curr Opin Infect Dis       Date:  2003-10       Impact factor: 4.915

4.  Approach to a child with acute flaccid paralysis.

Authors:  Sunit C Singhi; Naveen Sankhyan; Ravi Shah; Pratibha Singhi
Journal:  Indian J Pediatr       Date:  2012-07-12       Impact factor: 1.967

5.  Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients.

Authors:  Giuseppe Gerna; Giulia Campanini; Francesca Rovida; Elena Percivalle; Antonella Sarasini; Antonietta Marchi; Fausto Baldanti
Journal:  J Med Virol       Date:  2006-07       Impact factor: 2.327

6.  Detection of four human coronaviruses in respiratory infections in children: a one-year study in Colorado.

Authors:  Samuel R Dominguez; Christine C Robinson; Kathryn V Holmes
Journal:  J Med Virol       Date:  2009-09       Impact factor: 2.327

7.  Coronavirus infections in hospitalized pediatric patients with acute respiratory tract disease.

Authors:  Monika Jevšnik; Tina Uršič; Nina Zigon; Lara Lusa; Uroš Krivec; Miroslav Petrovec
Journal:  BMC Infect Dis       Date:  2012-12-20       Impact factor: 3.090

8.  Clinical impact of human coronaviruses 229E and OC43 infection in diverse adult populations.

Authors:  Edward E Walsh; Jae Hyun Shin; Ann R Falsey
Journal:  J Infect Dis       Date:  2013-08-06       Impact factor: 5.226

  8 in total
  29 in total

Review 1.  Potential neurological impact of coronaviruses: implications for the novel SARS-CoV-2.

Authors:  Joy D Iroegbu; Chibuzor W Ifenatuoha; Omamuyovwi M Ijomone
Journal:  Neurol Sci       Date:  2020-05-18       Impact factor: 3.307

2.  Neuroradiologists, Be Mindful of the Neuroinvasive Potential of COVID-19.

Authors:  M Morris; V M Zohrabian
Journal:  AJNR Am J Neuroradiol       Date:  2020-04-30       Impact factor: 3.825

3.  Axonal Transport Enables Neuron-to-Neuron Propagation of Human Coronavirus OC43.

Authors:  Mathieu Dubé; Alain Le Coupanec; Alan H M Wong; James M Rini; Marc Desforges; Pierre J Talbot
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

Review 4.  Neurology and the COVID-19 Pandemic: Gathering Data for an Informed Response.

Authors:  Brigit High; Alison M Hixon; Kenneth L Tyler; Amanda L Piquet; Victoria S Pelak
Journal:  Neurol Clin Pract       Date:  2021-04

5.  Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review.

Authors:  V Montalvan; J Lee; T Bueso; J De Toledo; K Rivas
Journal:  Clin Neurol Neurosurg       Date:  2020-05-15       Impact factor: 1.876

Review 6.  Infectivity of human coronavirus in the brain.

Authors:  Qi Cheng; Yue Yang; Jianqun Gao
Journal:  EBioMedicine       Date:  2020-05-28       Impact factor: 8.143

7.  Potential differences in cleavage of the S protein and type-1 interferon together control human coronavirus infection, propagation, and neuropathology within the central nervous system.

Authors:  Alain Le Coupanec; Marc Desforges; Benedikt Kaufer; Philippe Dubeau; Marceline Côté; Pierre J Talbot
Journal:  J Virol       Date:  2021-02-24       Impact factor: 5.103

Review 8.  SARS-CoV-2 Infection and Guillain-Barré Syndrome: A Review on Potential Pathogenic Mechanisms.

Authors:  Shahrzad Shoraka; Maria Lucia Brito Ferreira; Seyed Reza Mohebbi; Amir Ghaemi
Journal:  Front Immunol       Date:  2021-05-10       Impact factor: 7.561

9.  Systematic review of cases of acute myelitis in individuals with COVID-19.

Authors:  Eva C Schulte; Larissa Hauer; Alexander B Kunz; Johann Sellner
Journal:  Eur J Neurol       Date:  2021-07-12       Impact factor: 6.288

Review 10.  Coronaviruses and the central nervous system.

Authors:  Susan Morgello
Journal:  J Neurovirol       Date:  2020-07-31       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.